Skip navigation links
Press Releases
News from Turkey
Publications
Upcoming Tenders
Links
Videos
Newsletter Subscription
This page is print preview page.
Click here to return to the page.
Print page
News
 
Zentiva plans to make Turkey a “generics hub” 
30.07.2012

Hurriyet - Czech generic drugs company Zentiva has announced its plans to shift the majority of its production to its plant in Turkey in a bid to make the country an export base for over 34 countries. A subsidiary of French pharma giant Sanofi, Zentiva acquired the generics business of Turkish drug manufacturer Eczacibasi in 2007. Following its entry, the generics unit of Sanofi has turned the Luleburgaz, Kirklareli plant in western Turkey into one of the biggest research and development (R&D) labs of the group.

“Zentiva’s Turkish plant will be a supply base for generic drugs after their production moves to Turkey,” according to Zentiva’s President Jérôme Silvestre. Speaking to the press at the company’s headquarters in Prague, Czech Republic, Zentiva head said that Luleburgaz plant was issued with quality compliance awards from 13 countries including the US, Germany, Australia and Denmark, effectively becoming a production hub for the growing global generics markets.

Generics constitute more than 40 percent of the global pharma market with a volume of USD 100 billion. Generic drugs sector, with much lower development and production costs, continue to thrive especially in emerging countries. Around 80 percent of drug sales in Turkey consist of generics, making up of about 50 percent of the sectoral turnover. The country has witnessed sizeable takeovers and partnerships in pharma sector in recent years, the latest being the acquisition of local generics manufacturer Mustafa Nevzat by US biotech giant Amgen for USD 700 million.
17.05.2018 President Erdoğan’s UK visit cements Turkey as top strategic partner
10.05.2018 Germany’s Thyssenkrupp opens escalator factory in Kocaeli
02.05.2018 Denmark’s DFDS takes over Turkish ocean forwarder U.N. RO-RO for EUR 950 million
20.04.2018 Cisco commissions innovation center Istanbul at ITU ARI Teknokent
14.04.2018 Swiss journalists get first-hand insight into turkey’s investment climate
11.04.2018 Turkey unveils super incentives for high-impact investments
26.03.2018 Turkey introduces amendment laws for improvement of investment environment
19.03.2018 Turkey on display: opportunities for French investors
12.03.2018 Turkey-China relations: growing and delivering benefits for both countries
06.03.2018 Ispat holds investment seminars in Japan
<<
1 2 3 4 5 6 7 8 9 10
>>